Genzyme is currently organized into two business units – Rare Diseases and Multiple Sclerosis.
Our business units establish a structure for developing and marketing our products - but Genzyme encourages synergies across the company, and we believe it is this sharing of knowledge, ideas, and resources that leads to our most innovative, life-changing work. By collaborating together, we can fulfill Genzyme’s mission to develop and deliver transformative therapies for patients with unmet medical needs.